Effects of Chronic Chlorpromazine Treatment on Peripheral Benzodiazepine Binding Sites in Heart, Kidney, and Cerebral Cortex of Rats

Moshe Gavish*, Ronit Weizman

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

11 Scopus citations

Abstract

Abstract: Daily intraperitoneal administration to rats of 5 mg/kg of chlorpromazine (CPZ) for 21 days induced a significant up‐regulation (51%) of peripheral benzodiazepine binding sites (PBSs) in cerebral cortex and a down‐regulation of PBSs in the heart (25%) and kidney (14%), whereas no alteration in [3H]flunitrazepam binding in cerebral cortex was observed. [3H]PK 11195 binding to cerebral cortex returned to normal following 5 days of CPZ withdrawal, whereas the density of PBSs in the heart and kidney remained reduced. The affinity of PBSs for the ligand [3H]PK 11195 in the cerebral cortex and heart was not affected by the drug treatment or withdrawal. The CPZ‐induced alterations in PBSs may be relevant to the effects of the drug on CNS and/or peripheral organs.

Original languageEnglish
Pages (from-to)1553-1558
Number of pages6
JournalJournal of Neurochemistry
Volume52
Issue number5
DOIs
StatePublished - May 1989

Keywords

  • Central benzodiazepine receptors
  • Chlorpromazine
  • Peripheral benzodiazepine binding sites
  • [H]PK 11195

Fingerprint

Dive into the research topics of 'Effects of Chronic Chlorpromazine Treatment on Peripheral Benzodiazepine Binding Sites in Heart, Kidney, and Cerebral Cortex of Rats'. Together they form a unique fingerprint.

Cite this